Cure Ayurvedic: Making Traditional Wellness Relevant To Modern India

Debolina Das, Co-Founder & Director

Debolina Das

Co-Founder & Director

India’s Ayurvedic herbal products industry is moving beyond the familiar proposition of tradition and natural ingredients. As consumers become more informed, the conversation is increasingly about what is inside a product, where its ingredients come from, how consistently it is for­mulated and whether it can fit into an everyday wellness routine. This is creating room for suppliers that can retain the fundamentals of Ayurveda while responding to con­temporary expectations around quality, convenience and transparency.

Cure Ayurvedic is addressing this intersection with a focused portfolio spanning joint and musculoskeletal wellness, calcium support, diabetes and sugar management, gout care, energy and vitality, and hair care. The company’s approach emerged from Co-Founder & Director, Debolina Das’ experience of seeing consumers actively seek Ayurvedic alternatives but often struggle with inconsistent products, unclear sourcing and formulations that were inconvenient for regular use.

Her experience with Cure My Knee, a separate healthcare services vertical working with orthopaedic and musculoskeletal patients, provided another important insight. Patients frequently wanted to explore Ayurveda before moving towards more intensive interventions, yet their experience with available products did not always meet expectations. This gap led to the development of Cure Ayurvedic, with formulation quality becoming central to its proposition.

A Portfolio Built Around Specific Needs

Rather than pursuing breadth for the sake of scale, Cure Ayurvedic has chosen categories based on identifiable wellness requirements. Musculoskeletal care was a natural starting point, resulting in formulations for joint support, calcium supplementation, gout management and topical joint care.

VedicFlx, for instance, is developed using A2 cow ghee as its base and follows a traditional Ayurvedic processing method- Siddha Ghrita, in which selected herbs are processed over an extended duration before being encapsulated in a soft-gel format. Its VedicCal-Calcium Support has similarly been conceived as a herbal option for people seeking everyday bone health.

“The company subsequently expanded into metabolic wellness with D Vedic, a product focused on blood sugar management, while Vedic Shilajit supports energy and vitality. Its hair-care offering, Kesholekha Jadibuti Hair Oil, uses cold-pressed coconut oil as a base, enriched with ingredients including Brahmi, methi, kalonji and bhringraj”, says Debolina Das.

The company views Ayurveda as part of a longer-term approach to wellness and believes in quality, authenticity, purposeful formulations, and consumer education

Debolina Das, Co-Founder & Director

Product selection begins well before manufacturing. The team studies consumer requirements and traditional Ayurvedic references, consults Ayurvedic doctors, evaluates ingredients and considers whether a formulation can be produced consistently and safely. This selective process allows the company to keep its range centred on defined consumer needs rather than market trends.

Bringing Discipline to Traditional Formulations

For Cure Ayurvedic, making Ayurveda contemporary is less about changing its foundations and more about improving the way traditional knowledge reaches consumers. The company works with Vaidyas and Ayurvedic practitioners, studies established references and explores medicinal ingredients originating from different regions of India.

Where suitable, standardised extracts are incorporated to help maintain consistent ingredient strength across batches. Traditional preparation methods are retained where relevant, but finished products are offered in practical formats such as capsules, tablets, syrups and oils. This enables consumers to integrate them more easily into existing routines.

Manufacturing and quality control provide the other half of this approach. The company works through licensed, GMP-compliant manufacturing processes, supported by batch-level checks and third-party testing where required. Its website also highlights ISO-certified processes alongside its quality framework.

Modern equipment supports production, but Cure Ayurvedic remains clear that automation is not intended to replace Ayurvedic formulation principles. Instead, technology is used where it can improve manufacturing control and consistency while traditional knowledge continues to guide ingredient selection and preparation.

Trust Through Transparency

Trust remains one of the more difficult challenges in a crowded herbal-products market. For Debolina, an Ayurvedic label alone cannot establish credibility. Consumers increasingly examine ingredients, compare alternatives and seek information before deciding what to purchase. “Cure Ayurvedic responds by making transparency part of its consumer engagement. Ingredient information and proportions are communicated through labels, while digital communication is used to explain the purpose of formulations and the role of individual ingredients. Equally important is avoiding the promise of instant outcomes. The company views Ayurveda as part of a longer-term approach to wellness and believes expectations should be communicated accordingly”, highlights Debolina Das.

This becomes particularly relevant as online buying changes the category. Reviews, digital research and virtual interactions increasingly influence wellness purchases, giving brands an opportunity to build relationships directly rather than relying solely on the retail shelf. Cure Ayurvedic currently delivers across India, providing an established base for this direct-to-consumer reach.

Deepening the India Opportunity

The company’s next phase will prioritise deeper penetration within India rather than immediate international expansion. Despite its existing PAN-India reach, Cure Ayurvedic sees considerable headroom in bringing organised Ayurvedic wellness products to more households and strengthening its presence across domestic markets.

Alongside distribution expansion, new formulations will gradually broaden the portfolio. Plant-based protein is one area under consideration, reflecting growing demand for natural everyday nutrition. Further product development will continue to draw on Ayurvedic texts, practitioner inputs, ingredient research and testing.

International markets remain a longer-term possibility, but the company intends to approach them only after studying differences in consumer profiles, regulatory requirements and formulation needs. That measured roadmap reflects Cure Ayurvedic’s larger objective: to build scale without turning Ayurveda into another fast-moving product category, and instead establish a wellness brand where traditional knowledge, disciplined formulation and modern consumer expectations can coexist.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.